Efficacy of flecainide for the reversion of acute onset atrial fibrillation
Authors:
- Geoffrey J. DobbGDGeoffrey J. Dobb
- Leigh J. CoombsLCLeigh J. Coombs
- Kok-Yeng LeeKLKok-Yeng Lee
- John N. WeekesJWJohn N. Weekes
- Challon J. MurdockCMChallon J. Murdock
- Geoffrey M. ClarkeGCGeoffrey M. Clarke
- 1 August 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (5) , A50-A55
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.Heart, 1990
- Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythmThe American Journal of Cardiology, 1989
- Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillationThe American Journal of Cardiology, 1988
- Statistics in Medicine: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and ratesBMJ, 1988
- Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus RhythmAnnals of Internal Medicine, 1987
- Intravenous flecainide acetate for the clinical management of paroxysmal tachycardiasClinical Cardiology, 1987
- FlecainideNew England Journal of Medicine, 1986
- Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.Heart, 1982
- Some statistical methods useful in circulation research.Circulation Research, 1980